A patient with imported fire ant (IFA) hypersensitivity is scheduled to begin allergen immunotherapy with whole body fire ant extract. The allergist determines that the patient will begin therapy receiving one dose of the whole body fire ant extract every 4 weeks for 12 months. At the first patient visit, the allergist prepares 12 doses of the whole body fire ant extract that will be stored at the office for the patient for the duration of the 12 months of scheduled treatment. How is the provision of this service reported? ...
Subscribe or sign in to view the full article.
Article Overview
This coding article discusses how to report allergen immunotherapy services when a patient is beginning treatment for imported fire ant hypersensitivity using whole body extract. It is aimed at coding professionals, allergists, and billing staff who need to understand the CPT categories involved in extract preparation, office-based administration, and the distinction between different immunotherapy service types. The article also touches on general payer-policy considerations and the broader allergy and clinical immunology code set context.
Why This Topic Matters
Proper reporting of allergen immunotherapy depends on whether the service includes extract preparation, provision, or only administration. The article helps readers distinguish the relevant CPT services for a specific fire ant hypersensitivity scenario and avoid misclassification across related immunotherapy codes.
Article Sections
-
Scenario and reporting question
Introduces a patient beginning allergen immunotherapy for imported fire ant hypersensitivity and frames the reporting issue for the planned treatment course.
-
Code reporting guidance for extract preparation and injections
Discusses the CPT services referenced for preparation of allergen extract and administration of the initial and subsequent injections. It also addresses the relationship among the referenced immunotherapy codes in a general way.
-
CPT coding context and payer note
Provides a brief note about CPT guidance versus third-party payer policy and includes general allergy and clinical immunology code set context.
What You Will Learn
- How the article frames reporting for imported fire ant allergen immunotherapy
- Which CPT immunotherapy service categories are discussed for extract preparation and injection administration
- Why payer policy may differ from CPT guidance in this scenario
- How the article distinguishes office-based immunotherapy services at a broad level
Who Should Read This
- Medical coders
- Billing staff
- Allergists
- Clinical documentation staff
- Revenue cycle professionals
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com